YZG-331
Also called N6-[(S)-1-(phenyl)-propyl]-adenosine
Overview
YZG-331, also known as N⁶-[(S)-1-(phenyl)propyl]adenosine, is an adenosine receptor agonist which is or was under investigation for the potential treatment of insomnia.[1]
Drug class
Adenosine receptor agonist Sedative Hypnotic WP
From the Wikipedia article's infobox.
Pharmacology
Pharmacology
The drug appears to act through the adenosine A₁ and A2A receptors. It produces sedative and hypnotic effects and hypolocomotion in animals. The drug is orally active and crosses the blood–brain barrier, although its intestinal absorption and central permeability may be reduced by its P-glycoprotein substrate activity. It is a synthetic derivative of adenosine and of N⁶-(4-hydroxybenzyl)adenine riboside (NHBA). The latter compound is found in the traditional Chinese medicinal herb Gastrodia elata.[3]
Chemistry
- Formula
- C19H23N5O4 PC
- Molar mass (g/mol)
- 385.4 PC
- IUPAC name (computed by PubChem)
- (2R,
3S, PC4R, 5R) - 2- (hydroxymethyl) - 5- [6- [[(1S) - 1- phenylpropyl] amino] purin- 9- yl] oxolane- 3, 4- diol - SMILES
- CC[C@@H]
(C1=CC=CC=C1) PCNC2=C3C(=NC=N2) N(C=N3) [C@H] 4[C@@H] ([C@@H] ([C@H] (O4) CO) O) O - InChIKey
- RRRLUFHDFDNPMZ-
BPAMBQHCSA- PCN - PubChem CID
- 54282370
Harm reduction information
No harm reduction data is on file for this compound yet. That means no dose, timing or combination data from PsychonautWiki or TripSit. Please don't guess a dose from similar compounds. If you have taken it and feel unwell, contact emergency services or a poison control center.
User reports
Erowid erowid.org
ListingsBluelight bluelight.org
ListingsReddit reddit.com
ListingsPop culture
No references added yet.
Add a reference
Registered users can add songs, films, books, shows, games and art about this substance. Link a source that names the substance, such as the work's Wikipedia article, a review or an interview, not only the work itself. Entries are voted on and moderated like every other value on this page.
Opens when accounts launch.
Sources
- Other Delving into the Latest Updates on YZG-331 with Synapse. 8 May 2025
- Journal / agency Atkin T, Comai S, Gobbi G. Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery. Pharmacological Reviews. April 2018. doi:10.1124/pr.117.014381 · PMID 29487083
- Journal / agency Tang B, Yu Y, Yu F, Fang J, Wang G, Jiang J, Han Q, Shi J, Zhang J. The mechanism study of YZG-331 on sedative and hypnotic effects. Behavioural Brain Research. June 2022. doi:10.1016/j.bbr.2022.113885 · PMID 35398229
- Journal / agency Chaturvedi S, Rashid M, Malik MY, Agarwal A, Singh SK, Gayen JR, Wahajuddin M. Neuropharmacokinetics: a bridging tool between CNS drug development and therapeutic outcome. Drug Discovery Today. May 2019. doi:10.1016/j.drudis.2019.02.007 · PMID 30898661
- Journal / agency Liu Z, Mi J, Yang S, Zhao M, Li Y, Sheng L. Effects of P-glycoprotein on the intestine and blood-brain barrier transport of YZG-331, a promising sedative-hypnotic compound. European Journal of Pharmacology. November 2016. doi:10.1016/j.ejphar.2016.08.039 · PMID 27612629
Text and values on this page are quoted from Wikipedia (CC BY-SA 4.0), PubChem (public domain). Each value links to the exact revision it came from.